SCHEMBL2184655

SCHEMBL2184655

CNCCNCc1nnc2c(n1)c(=O)n(C)c(=O)n2Cc1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
HIF1A Q16665 4/20 0.41
HTT P42858 1/20 0.41
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GRIN1 Q05586 5/20 0.39
GRIN2B Q13224 5/20 0.39
PKM P14618 2/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179399 0.95 ALDH1A1 (0.42) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2181364 0.92 ALDH1A1 (0.42) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2183111 0.91 ALDH1A1 (0.42) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2182813 0.90 ALDH1A1 (0.42) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2183469 0.89 ALDH1A1 (0.41) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2179030 0.89 ALDH1A1 (0.41) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2181423 0.88 ALDH1A1 (0.41) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2184151 0.87 HIF1A (0.41) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2184193 0.87 HIF1A (0.40) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2
SCHEMBL2182625 0.87 CHRNB2 (0.40) ALDH1A1HIF1AHTTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR ALDH1A1 245/4885HIF1A 3662/4885HTT 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.